Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL STI-3031 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL STI-3031 .LAMBDA.-CHAIN, DIMER

Clinical Stage III Cutaneous Melanoma AJCC v8

Mayo Clinicmonoclonal_antibodyPhase 1Active
CC
40/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
26/ 100
Competitive Position
81/ 100

Competitive context

151 Active assets in the Clinical Stage III Cutaneous Melanoma AJCC v8 cohort.

Asset / SponsorPhaseRating
Alpha-Interferon
MIPO Clinic
Phase 3BBB
DACARBAZINE
Linnaeus Therapeutics, Inc.
Phase 3BBB
TIL
City of Hope Medical Center
Phase 2BBB
CIS-DIAMMINEDICHLOROPLATINUM II
MIPO Clinic
Phase 3BBB
Tyrosinase Peptide
University of Southern California
Phase 3BBB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL STI-3031 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL STI-3031 .LAMBDA.-CHAIN, DIMER is also rated in:

metastatic neoplasmDormant
CCC
Indicative ·
51 / 100
View asset →
refractory malignant neoplasmDormant
CC
Indicative ·
47 / 100
View asset →
biliary tract cancerDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →